RFA-AG-23-024 |
See Related
|
NIA |
05/06/2022 |
09/20/2022
|
10/21/2022
|
R01
|
Policy and Alzheimers Disease (AD) and Alzheimers Disease-Related Dementias (ADRD) Healthcare Disparities: Access, Utilization, and Quality (R01 Clinical Trial Not Allowed) |
RFA-AG-23-031 |
See Related
|
NIA |
04/25/2022 |
09/17/2022
|
10/18/2022
|
R03
|
Grants for Early Medical/Surgical Specialists Transition to Aging Research (GEMSSTAR) (R03 Clinical Trial Optional) |
RFA-AG-23-019 |
See Related
|
NIA |
04/21/2022 |
09/18/2022
|
10/19/2022
|
R01
|
Demonstration Projects to Promote Use of Interoperable Health Records in Clinical Research (R01 Clinical Trial Not Allowed) |
RFA-AG-23-028 |
See Related
|
NIA |
04/19/2022 |
06/15/2022
|
07/16/2022
|
R01
|
Neuronal Vulnerability to Proteinopathies in Alzheimers Disease and Alzheimers Disease-Related Dementias (R01 Clinical Trial Not Allowed) |
RFA-AG-23-016 |
See Related
|
NIA |
04/11/2022 |
09/21/2022
|
10/19/2024
|
F99/K00
|
Transition to Aging Research for Predoctoral Students (F99/K00 Clinical Trial Not Allowed) |
PAR-22-130 |
See Related
|
NIA |
03/10/2022 |
08/25/2022
|
09/08/2025
|
P01
|
NIA Program Project Applications (P01 Clinical Trial Optional) |
RFA-AG-23-011 |
See Related
|
NIA |
02/28/2022 |
06/15/2022
|
07/16/2022
|
R21
|
Noncoding RNAs in Alzheimers Disease and Related Dementias (R21 Clinical Trial Not Allowed) |
RFA-AG-23-010 |
See Related
|
NIA |
02/28/2022 |
06/15/2022
|
07/16/2022
|
R01
|
Noncoding RNAs in Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed) |
RFA-AG-23-015 |
See Related
|
NIA |
02/25/2022 |
09/11/2022
|
10/12/2022
|
R01
|
Studies of Cytosolic DNAs in the Interactions of Aging Hallmarks (R01 Clinical Trial Not Allowed) |
RFA-AG-23-013 |
See Related
|
NIA |
02/25/2022 |
09/11/2022
|
10/12/2022
|
R01
|
Mapping Interconnectivity Among Hallmarks of Aging under Lifespan Modifications (R01 Clinical Trial Not Allowed) |
RFA-AG-23-012 |
See Related
|
NIA |
02/25/2022 |
09/11/2022
|
10/12/2022
|
R01
|
Inter-Organelle Communication as a Platform to Interrogate the Interactions of Hallmarks of Aging (R01 Clinical Trial Not Allowed) |
RFA-AG-23-007 |
See Related
|
NIA |
02/23/2022 |
06/11/2022
|
07/12/2022
|
U24
|
Screening for Cognitive Impairment: Decision-Making (U24 Clinical Trial Optional) |
RFA-AG-23-014 |
See Related
|
NIA |
02/22/2022 |
06/01/2022
|
07/02/2022
|
R01
|
Mechanisms of Brain Hypoperfusion in AD/ADRD (R01 Clinical Trial Not Allowed) |
RFA-AG-23-005 |
See Related
|
NIA |
02/17/2022 |
06/01/2022
|
07/02/2022
|
R61/R33
|
Health Equity and the Cost of Novel Treatments for Alzheimers Disease and Related Dementias (R61/R33 Clinical Trial Not Allowed) |
PAR-22-110 |
See Related
|
NIA |
02/03/2022 |
04/25/2022
|
09/26/2024
|
U24
|
NIA Renewal and Revision Cooperative Agreements in AD/ADRD Research (U24 Clinical Trial Not Allowed) |
PAR-21-360 |
See Related
|
NIA |
01/10/2022 |
02/04/2022
|
01/08/2025
|
R61
|
Pilot Studies for the Spectrum of Alzheimers Disease/Alzheimers Disease-Related Dementias and Age-Related Cognitive Decline (R61 Clinical Trial Optional) |
PAR-21-359 |
See Related
|
NIA |
01/10/2022 |
02/04/2022
|
01/08/2025
|
R01
|
Early and Late Stage Clinical Trials for the Spectrum of Alzheimers Disease/Alzheimers Related Dementias and Age-Related Cognitive Decline (R01 Clinical Trial Optional) |
PAR-22-362 |
See Related
|
NIA |
01/07/2022 |
01/28/2022
|
10/02/2024
|
U01
|
NIA Renewal and Competing Revision Cooperative Agreements in Aging Research (U01 Clinical Trial Optional) |
RFA-AG-23-008 |
See Related
|
NIA |
01/05/2022 |
05/14/2022
|
06/16/2022
|
U01
|
Pharmacokinetic and Pharmacodynamic (PK/PD) Studies of mTOR Inhibitors on Aging-Related Indications (U01 Clinical Trial Required) |
RFA-AG-23-009 |
See Related
|
NIA |
12/28/2021 |
05/15/2022
|
06/15/2022
|
R01
|
Lipids in Brain Aging and Alzheimer's Disease (AD) and its Related Dementias (ADRD) (R01 Clinical Trial Not Allowed) |
PAR-22-094 |
See Related
|
NIA |
12/22/2021 |
02/11/2022
|
11/13/2024
|
R21
|
Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R21 Clinical Trial Optional) |
PAR-22-093 |
See Related
|
NIA |
12/22/2021 |
02/11/2022
|
11/13/2024
|
R01
|
Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R01 Clinical Trial Optional) |
PAR-22-077 |
See Related
|
NIA |
12/22/2021 |
02/15/2022
|
10/18/2024
|
U54
|
NIA Renewal and Revision Cooperative Agreements in AD/ADRD Research (U54 Clinical Trial Optional) |
PAR-22-047 |
See Related
|
NIA |
11/15/2021 |
01/05/2022
|
11/06/2024
|
U01
|
Alzheimer's Drug-Development Program (U01 Clinical Trial Optional) |
PAR-21-351 |
See Related
|
NIA |
09/28/2021 |
01/12/2022
|
01/08/2025
|
K22
|
NIA Career Transition Award (K22 Independent Clinical Trial Not Allowed) |
PAR-21-307 |
See Related
|
NIA |
08/11/2021 |
09/10/2021
|
02/14/2024
|
R01
|
Dementia Care and Caregiver Support Intervention Research (R01 Clinical Trial Required) |
PAR-21-308 |
See Related
|
NIA |
08/11/2021 |
09/10/2021
|
02/14/2024
|
R61/R33
|
Pragmatic Trials for Dementia Care and Caregiver Support (R61/R33 Clinical Trial Required) |
PAR-21-218 |
See Related
|
NIA |
05/28/2021 |
07/08/2021
|
08/09/2024
|
F31
|
NIA Predoctoral Fellowship Award to Promote Diversity in Translational Research for AD/ADRD (F31) |
PAR-21-217 |
See Related
|
NIA |
05/28/2021 |
07/08/2021
|
08/09/2024
|
F32
|
NIA Postdoctoral Fellowship Award to Promote Diversity in Translational Research for AD/ADRD (F32 Clinical Trial Not Allowed) |
PAR-21-220 |
See Related
|
NIA |
05/28/2021 |
05/12/2021
|
05/08/2024
|
K99/R00
|
NIA Advanced Postdoctoral Career Transition Awards to Promote Diversity in Translational Research for AD/ADRD (K99/R00 Clinical Trial Not Allowed) |
PAR-21-212 |
See Related
|
NIA |
03/23/2021 |
05/05/2021
|
05/08/2024
|
U01
|
Limited Competition: Alzheimers Disease Sequencing Project Follow-Up Study 2.0 (ADSP FUS 2.0): The Diverse Population Initiative (U01 Clinical Trial Not Allowed) |
PAR-21-141 |
See Related
|
NIA |
03/04/2021 |
04/25/2021
|
09/08/2023
|
R25
|
AD/ADRD Clinical Trials Short Course (R25 Independent Clinical Trial Not Allowed) |
PAR-20-317 |
See Related
|
NIA |
01/26/2021 |
04/25/2021
|
05/26/2023
|
R25
|
NIA MSTEM: Advancing Diversity in Aging Research through Undergraduate Education (R25 - Independent Clinical Trial Not Allowed) |
PAR-21-106 |
See Related
|
NIA |
01/25/2021 |
05/12/2021
|
05/08/2024
|
K07
|
NIA Academic Leadership Career Award (K07 Independent Clinical Trial Not Allowed) |
PAR-21-112 |
See Related
|
NIA |
01/22/2021 |
04/25/2021
|
09/26/2023
|
T32
|
Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (T32) |
PAR-21-109 |
See Related
|
NIA |
01/11/2021 |
05/16/2021
|
05/08/2024
|
R21
|
Early Stage Investigator Research Using Nonhuman Primate (NHP) Models (R21 Clinical Trial Not Allowed) |
PAR-20-309 |
See Related
|
NIA |
11/24/2020 |
01/05/2021
|
01/08/2024
|
R01
|
Alzheimer's Clinical Trials Consortium (ACTC) Clinical Trials (R01 Clinical Trial Required) |
PAR-21-069 |
See Related
|
NIA |
11/23/2020 |
04/07/2021
|
01/08/2024
|
R21
|
Multidisciplinary Studies of HIV/AIDS and Aging (R21 Clinical Trial Optional) |
PAR-21-068 |
See Related
|
NIA |
11/23/2020 |
04/07/2021
|
01/08/2024
|
R01
|
Multidisciplinary Studies of HIV/AIDS and Aging (R01 Clinical Trial Optional) |
RFA-AG-21-021 |
See Related
|
NIA |
08/13/2020 |
01/03/2021
|
10/22/2022
|
K76
|
Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Clinical Trial Required) |
RFA-AG-21-020 |
See Related
|
NIA |
08/13/2020 |
01/03/2021
|
10/22/2022
|
K76
|
Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Independent Clinical Trial Not Allowed) |
PAR-20-156 |
See Related
|
NIA |
03/31/2020 |
05/05/2020
|
05/08/2023
|
R01
|
Translational Bioinformatics Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease (R01 Clinical Trial Optional) |
PAR-20-110 |
See Related
|
NIA |
02/07/2020 |
04/25/2020
|
01/26/2023
|
U24
|
National Institute on Aging Genetics of Alzheimer's Disease Data Storage Site (U24 Clinical Trial Not Allowed) |
PAR-20-099 |
See Related
|
NIA |
01/23/2020 |
04/25/2020
|
01/26/2023
|
U24
|
Harmonization of Alzheimers Disease and Related Dementias (AD/ADRD) Genetic, Epidemiologic, and Clinical Data to Enhance Therapeutic Target Discovery (U24 Clinical Trial Not Allowed) |
PAR-20-070 |
See Related
|
NIA |
12/09/2019 |
01/16/2020
|
11/17/2022
|
R21/R33
|
Research Infrastructure Development for Interdisciplinary Aging Studies (R21/R33 - Clinical Trial Optional) |
PAR-20-071 |
See Related
|
NIA |
12/09/2019 |
01/16/2020
|
11/17/2022
|
R33
|
Advanced-Stage Development and Utilization of Research Infrastructure for Interdisciplinary Aging Studies (R33 Clinical Trial Optional) |
PAR-19-394 |
See Related
|
NIA |
10/18/2019 |
01/16/2020
|
01/08/2023
|
R36
|
Aging Research Dissertation Awards to Increase Diversity (R36 Clinical Trial Not Allowed) |
PAS-19-391 |
See Related
|
NIA |
10/07/2019 |
01/16/2020
|
11/17/2022
|
R03
|
Small Research Grant Program for the Next Generation of Researchers in AD/ADRD Research: Area of Focus Archiving and Leveraging Existing Data Sets for Analyses (R03 Clinical Trial Not Allowed) |
PAS-19-392 |
See Related
|
NIA |
10/07/2019 |
01/16/2020
|
11/17/2022
|
R03
|
Small Research Grant Program for the Next Generation of Researchers in AD/ADRD Research: Area of Focus Basic Science (R03 Clinical Trials Not Allowed) |
PAS-19-393 |
See Related
|
NIA |
10/07/2019 |
01/16/2020
|
11/17/2022
|
R03
|
Small Research Grant Program for the Next Generation of Researchers in AD/ADRD Research: Area of Focus Systems Biology (R03 Clinical Trial Not Allowed) |
PAR-19-374 |
See Related
|
NIA |
09/13/2019 |
12/25/2019
|
09/26/2022
|
U19
|
Complex Integrated Multi-Component Projects in Aging Research (U19 Clinical Trial Optional) |
PAR-19-338 |
See Related
|
NIA |
08/09/2019 |
09/05/2019
|
07/06/2022
|
U01
|
Limited Competition: Renewals of, and Revisions and Resubmissions to, the Longitudinal Early-onset Alzheimers Disease Study (LEADS) Cooperative Agreement (U01 Clinical Trial Not Allowed) |
PAS-19-317 |
See Related
|
NIA |
07/18/2019 |
08/05/2019
|
09/07/2022
|
R41/R42
|
Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional) |
PAS-19-316 |
See Related
|
NIA |
07/18/2019 |
08/05/2019
|
09/07/2022
|
R43/R44
|
Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional) |
PAR-19-314 |
See Related
|
NIA |
07/12/2019 |
08/09/2019
|
05/26/2022
|
P01
|
NIA Program Project Applications (P01 Clinical Trial Optional) |
PAR-19-304 |
See Related
|
NIA |
06/25/2019 |
09/16/2019
|
07/17/2022
|
R33
|
Early-Stage T1 Translational Aging Research (Bench to Bedside) for the Development of Novel Therapeutics (R33 Clinical Trial Optional) |
PAR-19-305 |
See Related
|
NIA |
06/25/2019 |
09/16/2019
|
07/17/2022
|
R21/R33
|
Early-Stage T1 Translational Aging Research (Bench to Bedside) for the Development of Novel Therapeutics (R21/R33 Clinical Trial Optional) |
PAR-19-302 |
See Related
|
NIA |
06/24/2019 |
09/05/2019
|
09/08/2022
|
R01
|
NIA Multi-site Clinical Trial Implementation Grant (R01 Clinical Trial Required) |
PAR-19-298 |
See Related
|
NIA |
06/14/2019 |
09/05/2019
|
09/08/2022
|
R01
|
Non-Invasive Neurostimulation in AD/ADRD (R01 Clinical Trial Optional) |
PAR-19-288 |
See Related
|
NIA |
05/23/2019 |
08/25/2019
|
09/26/2022
|
U54
|
Limited Competition: NIA Genome Center for Alzheimer's Disease (U54 Clinical Trial Not Allowed) |
PAR-19-269 |
See Related
|
NIA |
05/06/2019 |
09/05/2019
|
09/08/2022
|
U01
|
Cognitive Systems Analysis of Alzheimer's Disease Genetic and Phenotypic Data (U01 Clinical Trial Not Allowed) |
PA-19-230 |
See Related
|
NIA |
03/28/2019 |
05/05/2019
|
07/06/2022
|
U01
|
Pragmatic clinical trial on efficacy of managing reduced iron stores on risk of clinically important events in older adults with heart failure and anemia (U01 Clinical Trial Required) |